Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neuropsychological profile of French adults with early-treated phenylketonuria: a multicenter study.
Brachet M, Charrière S, Douillard C, Feillet F, Fouilhoux A, Astudillo L, Lavigne C, Arnoux JB, Odent S, Gay C, Schiff M, Mazodier K, Kuster A, Rigalleau V, Thauvin-Robinet C, Leguy-Seguin V, Gissot V, Maillot F. Brachet M, et al. Among authors: leguy seguin v. J Neurol. 2024 Dec 12;272(1):53. doi: 10.1007/s00415-024-12840-0. J Neurol. 2024. PMID: 39666084
Clinical phenotype of adult-onset systemic histiocytosis harboring BRAF in-frame deletions.
Papo M, Razanamahéry J, Da Silva M, Hélias-Rodzewicz Z, Potapenko V, Bota S, Leguy-Seguin V, Dominique S, Lhote R, Moyon Q, Taïeb D, Abrassart T, Campana M, Keo V, Rivière E, Lucidarme O, Cohen-Aubart F, Amoura Z, Haroche J, Emile JF. Papo M, et al. Among authors: leguy seguin v. Haematologica. 2024 Sep 1;109(9):3048-3052. doi: 10.3324/haematol.2024.285273. Haematologica. 2024. PMID: 38779720 Free PMC article. No abstract available.
Mass cytometry reveals atypical immune profile notably impaired maturation of memory CD4 T with Gb3-related CD27 expression in CD4 T cells in Fabry disease.
Mauhin W, Dzangue-Tchoupou G, Amelin D, Corneau A, Lamari F, Allenbach Y, Dussol B, Leguy-Seguin V, D'Halluin P, Matignon M, Maillot F, Ly KH, Besson G, Willems M, Labombarda F, Masseau A, Lavigne C, Lacombe D, Maillard H, Lidove O, Benveniste O. Mauhin W, et al. Among authors: leguy seguin v. J Inherit Metab Dis. 2024 Jul;47(4):818-833. doi: 10.1002/jimd.12727. Epub 2024 Apr 16. J Inherit Metab Dis. 2024. PMID: 38623626
Efficacy and safety of intravenous bevacizumab on severe bleeding associated with hemorrhagic hereditary telangiectasia: A national, randomized multicenter trial.
Dupuis-Girod S, Rivière S, Lavigne C, Fargeton AE, Gilbert-Dussardier B, Grobost V, Leguy-Seguin V, Maillard H, Mohamed S, Decullier E, Roux A, Bernard L, Saurin JC, Saroul N, Faure F, Cartier C, Altwegg R, Laccourreye L, Oberti F, Beaudoin M, Dhelens C, Desvignes C, Azzopardi N, Paintaud G, Hermann R, Chinet T. Dupuis-Girod S, et al. Among authors: leguy seguin v. J Intern Med. 2023 Dec;294(6):761-774. doi: 10.1111/joim.13714. Epub 2023 Aug 23. J Intern Med. 2023. PMID: 37592715 Clinical Trial.
Antiplatelet and anticoagulant therapies in hereditary hemorrhagic telangiectasia: A large French cohort study (RETROPLACOTEL).
Grobost V, Hammi S, Pereira B, Guilhem A, Duffau P, Seguier J, Parrot A, Gautier G, Alric L, Kerjouan M, Le Guillou X, Simon D, Chaussavoine L, Rondeau-Lutz M, Leguy-Seguin V, Delagrange L, Lavigne C, Maillard H, Dupuis-Girod S; French HHT group. Grobost V, et al. Among authors: leguy seguin v. Thromb Res. 2023 Sep;229:107-113. doi: 10.1016/j.thromres.2023.07.001. Epub 2023 Jul 6. Thromb Res. 2023. PMID: 37437516
Iodoacetamide blank compensation in FXIII functional assays: Is it still necessary?
Savard P, Leguy-Seguin V, Chavy C, Genre-Volot F, Callegarin A, Amiral J, Bonnotte B, Lecompte T, de Maistre E. Savard P, et al. Among authors: leguy seguin v. Int J Lab Hematol. 2023 Dec;45(6):969-971. doi: 10.1111/ijlh.14111. Epub 2023 Jun 8. Int J Lab Hematol. 2023. PMID: 37293692 No abstract available.
Development and validation of a quality of life measurement scale specific to hereditary hemorrhagic telangiectasia: the QoL-HHT.
Le TTT, Martinent G, Dupuis-Girod S, Parrot A, Contis A, Riviere S, Chinet T, Grobost V, Espitia O, Dussardier-Gilbert B, Alric L, Armengol G, Maillard H, Leguy-Seguin V, Leroy S, Rondeau-Lutz M, Lavigne C, Mohamed S, Chaussavoine L, Magro P, Seguier J, Kerjouan M, Fourdrinoy S. Le TTT, et al. Among authors: leguy seguin v. Orphanet J Rare Dis. 2022 Jul 19;17(1):281. doi: 10.1186/s13023-022-02426-2. Orphanet J Rare Dis. 2022. PMID: 35854330 Free PMC article.
Sphingosine-1-Phosphate Levels Are Higher in Male Patients with Non-Classic Fabry Disease.
Mauhin W, Tebani A, Amelin D, Abily-Donval L, Lamari F, London J, Douillard C, Dussol B, Leguy-Seguin V, Noel E, Masseau A, Lacombe D, Maillard H, Bekri S, Lidove O, Benveniste O. Mauhin W, et al. Among authors: leguy seguin v. J Clin Med. 2022 Feb 24;11(5):1233. doi: 10.3390/jcm11051233. J Clin Med. 2022. PMID: 35268324 Free PMC article.
36 results